Future Strategies Against Emerging and Evolving Pathogens: Lessons From COVID-19
Authors: Robert Carnahan, Lauriane Cabon, Kyoji Tsuchikama, Jerry Madukwe | Last updated: [30/08/2022]
Overview
Antibody-based therapeutics hold great promise in treatment and prevention of multiple diseases such as cancer and infectious diseases. Effective assays for functional characterization of antibody-based therapeutics are critical due to the time- and resource- consuming process of antibody-based therapeutics discovery.
In our on-demand webinar, we discuss recent advances in assay systems in the functional characterization of antibody-based therapeutics. Hear from experts in the field working on antibody-drug conjugates (ADCs), T-cell bispecifics, and other antibody discovery programs.
- Document type: Webinar
- Page count: 12
- Read time: Approx. 1 hour
Key Takeaways
- Cell-based platform for rapid antiviral therapeutic antibody discovery and characterization
- 3D culture platforms for predicting toxicity of cancer antibody-based therapeutics
- Using live-cell assays optimize ADC-based chemotherapies
This Resource is Designed for:
- Scientists, Lab technicians and Lab manager at Biopharma,/Pharma small Biotech & also large Academic institutions as well as university research centers, working on solutions for combat the COVID-19 pandemic and further researches around infectious diseases
Applications Supported:
- Vaccines and Therapeutics for COVID-19